GA
BSX icon

Geller Advisors’s Boston Scientific BSX Stock Holding History

Geller Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$695K Sell
7,784
-312
-4% -$27.5K 0.05% 97
2024
Q3 		$678K Buy
8,096
+510
+7% +$40.2K 0.05% 104
2024
Q2 		$584K Buy
7,586
+184
+2% +$13.5K 0.04% 120
2024
Q1 		$507K Buy
7,402
+157
+2% +$10.1K 0.04% 137
2023
Q4 		$419K Buy
7,245
+1,990
+38% +$106K 0.04% 158
2023
Q3 		$277K Buy
5,255
+147
+3% +$7.71K 0.03% 201
2023
Q2 		$276K Sell
5,108
-872
-15% -$45.5K 0.03% 196
2023
Q1 		$299K Buy
5,980
+979
+20% +$46.1K 0.04% 120
2022
Q4 		$231K Buy
+5,001
New +$217K 0.04% 133
2018
Q3 		– Sell
-2,757,666
Closed -$90.2M – 31
2018
Q2 		$90.2M Hold
2,757,666
– – 39.15% 1
2018
Q1 		$75.3M Hold
2,757,666
– – 36.77% 2
2017
Q4 		$68.4M Hold
2,757,666
– – 34.47% 2
2017
Q3 		$80.4M Hold
2,757,666
– – 39.41% 2
2017
Q2 		$76.4M Hold
2,757,666
– – 39.02% 2
2017
Q1 		$68.6M Hold
2,757,666
– – 37.08% 2
2016
Q4 		$59.6M Sell
2,757,666
-2,232
-0.1% -$48.7K 35.44% 2
2016
Q3 		$65.7M Buy
2,759,898
+2,232
+0.1% +$53.2K 37.41% 2
2016
Q2 		$64.4M Hold
2,757,666
– – 37.11% 2
2016
Q1 		$51.9M Hold
2,757,666
– – 31% 2
2015
Q4 		$50.9M Hold
2,757,666
– – 30.27% 2
2015
Q3 		$45.3M Hold
2,757,666
– – 28.9% 2
2015
Q2 		$48.8M Hold
2,757,666
– – 28.44% 2
2015
Q1 		$48.9M Hold
2,757,666
– – 28.32% 2
2014
Q4 		$36.5M Sell
2,757,666
-3,307
-0.1% -$42.3K 21.18% 3
2014
Q3 		$32.6M Buy
2,760,973
+2,638
+0.1% +$33.2K 18.39% 3
2014
Q2 		$35.2M Buy
2,758,335
+669
+0% +$8.7K 23.53% 2
2014
Q1 		$37.3M Hold
2,757,666
– – 24.79% 2
2013
Q4 		$33.1M Hold
2,757,666
– – 22.4% 2
2013
Q3 		$32.4M Hold
2,757,666
– – 24.35% 2
2013
Q2 		$25.6M Buy
+2,757,666
New +$23.4M 21.69% 2

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geller Advisors's BSX Position: Q4 2024 in Review

Geller Advisors reduced its Boston Scientific (BSX) stake by 3.9% in Q4 2024, selling an estimated $27.5K and leaving 7,784 shares worth $695K. The position accounts for 0.05% of the portfolio, ranked #97.

Geller Advisors first reported a position in BSX in Q2 2013 and has held it in 30 quarters since. The position peaked at $90.2M in Q2 2018. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Geller Advisors held 7,784 shares of Boston Scientific worth $695K as of Q4 2024.
  • Geller Advisors sold 312 Boston Scientific shares in Q4 2024, an estimated $27.5K.
  • Boston Scientific made up 0.05% of Geller Advisors's portfolio in Q4 2024, its #97 holding.
  • Geller Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 30 quarters since.
  • Geller Advisors's Boston Scientific position peaked at $90.2M in Q2 2018.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.